Abstract:The normal ageing process affects resistance arteries, leading to various functional and structural changes. Systolic hypertension is a common occurrence in human ageing, and it is associated with large artery stiffening, heightened pulsatility, small artery remodeling, and damage to critical microvascular structures. Starting from young adulthood, a progressive elevation in the mean arterial pressure is evidenced by clinical and epidemiological data as well as findings from animal models. The myogenic response, a protective mechanism for the microcirculation, may face disruptions during ageing. The dysregulation of calcium entry channels (L-type, T-type, and TRP channels), dysfunction in intracellular calcium storage and extrusion mechanisms, altered expression of potassium channels, and a change in smooth muscle calcium sensitization may contribute to the age-related dysregulation of myogenic tone. Flow-mediated vasodilation, a hallmark of endothelial function, is compromised in ageing. This endothelial dysfunction is related to increased oxidative stress, lower nitric oxide bioavailability, and a low-grade inflammatory response, further exacerbating vascular dysfunction. Resistance artery remodeling in ageing emerges as a hypertrophic response of the vessel wall that is typically observed in conjunction with outward remodeling (in normotension), or as inward hypertrophic remodeling (in hypertension). The remodeling process involves oxidative stress, inflammation, reorganization of actin cytoskeletal components, and extracellular matrix fiber proteins. Reactive oxygen species (ROS) signaling and chronic low-grade inflammation play substantial roles in age-related vascular dysfunction. Due to its role in the regulation of vascular tone and structural proteins, the RhoA/Rho-kinase pathway is an important target in age-related vascular dysfunction and diseases. Understanding the intricate interplay of these factors is crucial for developing targeted interventions to mitigate the consequences of ageing on resistance arteries and enhance the overall vascular health.

RhoA/rho kinase pathway activation in age-associated endothelial cell dysfunction and thrombosis

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK

Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Endothelial dysfunction and angiogenesis impairment in the ageing vasculature

Cellular and Molecular Determinants of Arterial Aging

Functional, Structural and Proteomic Effects of Ageing in Resistance Arteries

Age-Related Endothelial Dysfunction with Respect to Nitric Oxide, Endothelium-Derived Hyperpolarizing Factor and Cyclooxygenase Products

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

Rock the Rock of Atherosclerosis

Pathophysiological Effects Of Rhoa And Rho-Associated Kinase On Cardiovascular System

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis

Targeting vascular senescence in cardiovascular disease with aging

Cardiovascular aging: from cellular and molecular changes to therapeutic interventions

Impaired glycolysis in aged endothelial cells is associated with reduced neovascularisation upon tissue ischemia

The Role of Oxidative Stress and Inflammation in Cardiovascular Aging

Endothelial Cell Senescence and Age-Related Vascular Diseases

The role of senescence, telomere dysfunction and shelterin in vascular aging

The Role of Signaling Pathways of Inflammation and Oxidative Stress in Development of Senescence and Aging Phenotypes in Cardiovascular Disease